These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6115575

  • 1. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
    Canepa-Anson R, Dawson JR, Kuan P, Warnes CA, Poole-Wilson PA, Reuben SR, Sutton GC.
    Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR, Canepa-Anson R, Kuan P, Whitaker NH, Carnie J, Warnes C, Reuben SR, Poole-Wilson PA, Sutton GC.
    Br Med J (Clin Res Ed); 1981 May 02; 282(6274):1423-6. PubMed ID: 6112039
    [Abstract] [Full Text] [Related]

  • 3. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B, Hoback J, Francis GS, Hodges M, Asinger RW, Cohn JN, Taylor CR.
    Am Heart J; 1981 Sep 02; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    Awan NA, Needham K, Evenson MK, Hermanovich J, Joye JA, DeMaria AN, Mason DT.
    Am Heart J; 1981 Sep 02; 102(3 Pt 2):555-63. PubMed ID: 7270402
    [No Abstract] [Full Text] [Related]

  • 5. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW, Nelson HS.
    Pharmacotherapy; 1984 Sep 02; 4(1):1-10. PubMed ID: 6142449
    [Abstract] [Full Text] [Related]

  • 6. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W, Prince K, Whyte K, MacNee W, Flenley DC.
    Am Rev Respir Dis; 1989 Feb 02; 139(2):492-7. PubMed ID: 2563321
    [Abstract] [Full Text] [Related]

  • 7. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
    Bayliss J, Norell M, Canepa-Anson R, Reuben SR, Poole-Wilson PA, Sutton GC.
    Br Heart J; 1983 Mar 02; 49(3):214-21. PubMed ID: 6830658
    [Abstract] [Full Text] [Related]

  • 8. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
    Dawson JR, Canepa-Anson R, Kuan P, Reuben SR, Poole-Wilson PA, Sutton GC.
    Br Heart J; 1983 Sep 02; 50(3):282-9. PubMed ID: 6137226
    [Abstract] [Full Text] [Related]

  • 9. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF, Seecof RM, Reddy PS.
    Can J Cardiol; 1986 Sep 02; 2(2):80-5. PubMed ID: 3085906
    [Abstract] [Full Text] [Related]

  • 10. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
    Weber KT, Andrews V, Janicki JS, Likoff M, Reichek N.
    Circulation; 1982 Dec 02; 66(6):1262-7. PubMed ID: 6128086
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA, Evenson MK, Needham KE, Evans TO, Hermanovich J, Taylor CR, Amsterdam E, Mason DT.
    Circulation; 1981 Jan 02; 63(1):96-101. PubMed ID: 7438412
    [Abstract] [Full Text] [Related]

  • 12. [A study on tolerance to denopamine, oral beta 1-agonist].
    Hondo T, Kawagoe T, Morichika N, Nakagawa H, Yamagata T, Yuasa A, Tsuchioka Y, Matsuura H, Kajiyama G, Okamoto M.
    Kokyu To Junkan; 1990 Sep 02; 38(9):875-80. PubMed ID: 1978386
    [Abstract] [Full Text] [Related]

  • 13. [Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
    Inden M, Yamamuro M, Murayama S, Noda E, Tanimura H, Takasaki H, Konishi T, Nakano T, Takezawa H.
    Kokyu To Junkan; 1986 May 02; 34(5):541-6. PubMed ID: 3738247
    [No Abstract] [Full Text] [Related]

  • 14. Acute and long-term hemodynamic effects of oral pirbuterol in patients with chronic severe congestive heart failure: randomized double-blind trial.
    Pamelia FX, Gheorghiade M, Beller GA, Bishop HL, Olukotun AY, Taylor CR, Watson DD, Grunwald AM, Sirowatka J, Carabello BA.
    Am Heart J; 1983 Dec 02; 106(6):1369-76. PubMed ID: 6359846
    [Abstract] [Full Text] [Related]

  • 15. Management of severe chronic CHF with oral pirbuterol.
    Awan NA, Needham K, Evenson MK, Mason DT.
    Acta Med Scand Suppl; 1981 Dec 02; 652():155-62. PubMed ID: 6949462
    [No Abstract] [Full Text] [Related]

  • 16. Clinical studies with beta 2 adrenoceptor agonists in heart failure.
    Dawson JR, Bayliss J, Norell MS, Canepa-Anson R, Kuan P, Reuben S, Poole-Wilson PA, Sutton GC.
    Eur Heart J; 1982 Dec 02; 3 Suppl D():135-41. PubMed ID: 6130947
    [No Abstract] [Full Text] [Related]

  • 17. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI, Silke B, Barker MC, Saxton CA, Taylor SH.
    Eur Heart J; 1982 Jun 02; 3(3):238-45. PubMed ID: 6125392
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE, Turi Z, Brown EJ, Lorell BH, Colucci WS, Mudge GH, Taylor CR, Grossman W.
    Circulation; 1981 Jul 02; 64(1):139-45. PubMed ID: 7237712
    [Abstract] [Full Text] [Related]

  • 20. Effects of the beta-adrenergic receptor agonist pirbuterol on cardiac performance during acute ischaemic left ventricular failure in dogs.
    Smiseth OA.
    Eur J Pharmacol; 1983 Mar 04; 87(4):379-86. PubMed ID: 6133759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.